Search Details

Word: bst (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...Kessler managed to offend as well those who cheered his moves against Big Business. He approved olestra, a fat substitute that can cause diarrhea and cramps, and BST, a hormone injected into cows to increase milk production--arguing in both cases that his decision was based on sound science. The FDA under his regime was faulted for being too laggard in approving new drugs, even though Kessler cut the waiting time from 33 months to 19 months...

Author: /time Magazine | Title: A COMMISH MANY WILL MISS | 12/9/1996 | See Source »

Many experts believe that if Kessler decides to give the go-ahead to olestra, he may stipulate just such a re-evaluation. That's what happened in 1993, when the FDA approved BST, Monsanto's genetically engineered hormone that boosts milk production in cows. It required the company to report back in two years on the chemical's effects. As Kessler puts it, "There is this notion that up until the day we approve a product, the food or drug or device is unsafe. And all of a sudden, the day we approve a product, it's safe forever more...

Author: /time Magazine | Title: HEALTH: ARE WE READY FOR FAT-FREE FAT? | 1/8/1996 | See Source »

...similar controversy has blown up over CR's condemnation of bovine somatotropin (bst), a genetically engineered hormone to increase milk production in cows. Again, the magazine's original warning in the May 1992 issue (udder insanity) was widely reprinted, prompting consumer resistance to the use of bst on dairy cows. And again, a small battalion of other environmental watchdogs refuted the claims of danger, including the A.M.A. and the Food and Drug Administration...

Author: /time Magazine | Title: EVALUATING THE BUYER'S BIBLE | 2/20/1995 | See Source »

Dale Bauman, a Cornell University professor of nutritional biochemistry, claims that Consumer Reports erred in its bst story by relying solely on its in-house critic in the field, Michael Hansen, rather than a panel review. "Nobody has the credibility to handle a wide range of issues," Bauman says. He adds that he found a Hansen report on bst "replete with mistakes" and that the fda sent Hansen a letter listing all the errors. "I don't think this helps the magazine's credibility," Bauman observes...

Author: /time Magazine | Title: EVALUATING THE BUYER'S BIBLE | 2/20/1995 | See Source »

...technical policy and public-service director Edward Groth III calls the fda letter to Hansen "hogwash, a propaganda document put out to discredit his report." Groth defends Hansen's expertise and explains CR's position on bst: "The literature shows there is possibly a problem but no conclusive proof. Scientist A says we should be cautious. Scientist B says let's go ahead. Science sometimes carries more weight than it should. Science is good, but in policy you need value judgments...

Author: /time Magazine | Title: EVALUATING THE BUYER'S BIBLE | 2/20/1995 | See Source »

| 1 | 2 | 3 | Next